Confirmatory Study of HFVI Guided Analgesic Administration in Surgical Subjects

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 8, 2020

Primary Completion Date

January 9, 2024

Study Completion Date

January 9, 2024

Conditions
Analgesia
Interventions
DEVICE

HFVI

Subjects in the HFVI intervention group will be monitored in the same manner as the control group, but the HFVI monitor display will also be available to the anesthesia provider in real time. Bolus doses of 25ug or 50 ug of fentanyl will be recommended to be administered when the HFVI values begin to decrease below 50, and as needed based on the judgment of the clinician responsible for the case. All anesthetic medications that are given, patient events, and vital sign recordings will be included in the anesthetic record and data collection forms.

Trial Locations (1)

32209

UF Health Jacksonville, Jacksonville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mdoloris Medical Systems

UNKNOWN

lead

University of Florida

OTHER

NCT04049656 - Confirmatory Study of HFVI Guided Analgesic Administration in Surgical Subjects | Biotech Hunter | Biotech Hunter